Atlas FDA

VERIGENE GRAM POSITIVE BLOOD CULTURE NUCLEIC ACID TEST (BC-GP)

FDA 510(k) clearance DEN120014 · decided 2012-06-26

Clearance details

K-number
DEN120014
Device name
VERIGENE GRAM POSITIVE BLOOD CULTURE NUCLEIC ACID TEST (BC-GP)
Applicant
Nanosphere, Inc.
Decision
Unknown
Date received
2012-06-15
Decision date
2012-06-26
Days to decision
11 days
Clearance type
Post-NSE
Product code
PAM
Device class
2
Regulation number
866.3365
Medical specialty
Microbiology
Advisory committee
Microbiology
Location
Northbrook, IL, US
Third-party review
No
Expedited review
No

+ Add to Predicate Builder ◉ Watch Nanosphere

The Builder collects up to 8 candidate devices side by side with yours, then exports the substantial-equivalence comparison scaffold. How it works

Need this as data, not a web page?

Query all 176,000+ clearances through the Atlas FDA API, or subscribe to weekly change alerts. Self-serve from $29/mo.

Similar devices under this product code

Devices cleared under the same product code - the starting set for predicate research.

RecordFirmDate
QIAstat-Dx BCID GPF Plus AMR Panel (K254194)QIAGEN GmbH2026-08-06
LIAISON PLEX Gram-Positive Blood Culture Assay (K243490)Luminex Corporation2025-06-06
ePlex Blood Culture Identification Panel - Gram Positive (BCID-GP) Panel (K181663)Genmark Diagnostics, Incorporated2018-12-20
iC-GPC Assay TM for use on the iC-SystemTM (K163390)Icubate, Inc.2017-08-08
Great Basin Staph ID/R Blood Culture Panel (K152470)Great Basin Scientific, Inc.2016-03-25
VERIGENE GRAM-POSITIVE BLOOD CULTURE (GC-GP) NUCLEIC ACID TEST (K122514)Nanosphere, Inc.2012-09-19

Recalls involving this device

No recalls on record reference this clearance.